Intrinsic Value of S&P & Nasdaq Contact Us

Selecta Biosciences, Inc. SELB NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — SELB

Selecta Biosciences, Inc. (SELB) has a market capitalization of $135.2M and trades at $0.88. The 52-week range is 0.785-1.99.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-5.02, annual revenue of $2.8M.

The stock has a beta of 0.83, operates in the Healthcare sector.

Trading Data
Current Price$0.88
52-Week Range0.785-1.99
Volume2.76M
Avg Volume (30D)634.42K
Market Cap$135.2M
Beta (1Y)0.83
Company
IPO Date2016-06-22
Employees64
CEOCarsten Brunn
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS8162121045
CUSIP816212104
Income (Latest Year)
Revenue$2.8M
Net Income$-130.3M
EPS$-5.02
EPS Diluted$-5.02
Shares Outstanding$25.97M
Balance Sheet (Latest Year)
Total Assets$296.41M
Current Assets$129.28M
Cash & ST Investments$125.14M
Total Liabilities$422.65M
Total Debt$12.68M
Net Debt$-112.46M
Total Equity$-126.24M
Debt / Equity-0.10
Valuation Ratios
P/E Ratio-0.2
P/S Ratio48.34
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message